1. Home
  2. LIXT vs ZAPP Comparison

LIXT vs ZAPP Comparison

Compare LIXT & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • ZAPP
  • Stock Information
  • Founded
  • LIXT 2005
  • ZAPP 2017
  • Country
  • LIXT United States
  • ZAPP Thailand
  • Employees
  • LIXT N/A
  • ZAPP N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • ZAPP Motor Vehicles
  • Sector
  • LIXT Health Care
  • ZAPP Consumer Discretionary
  • Exchange
  • LIXT Nasdaq
  • ZAPP Nasdaq
  • Market Cap
  • LIXT 4.1M
  • ZAPP 3.7M
  • IPO Year
  • LIXT N/A
  • ZAPP N/A
  • Fundamental
  • Price
  • LIXT $1.38
  • ZAPP $0.29
  • Analyst Decision
  • LIXT
  • ZAPP
  • Analyst Count
  • LIXT 0
  • ZAPP 0
  • Target Price
  • LIXT N/A
  • ZAPP N/A
  • AVG Volume (30 Days)
  • LIXT 16.9K
  • ZAPP 8.9M
  • Earning Date
  • LIXT 05-12-2025
  • ZAPP 06-20-2025
  • Dividend Yield
  • LIXT N/A
  • ZAPP N/A
  • EPS Growth
  • LIXT N/A
  • ZAPP N/A
  • EPS
  • LIXT N/A
  • ZAPP N/A
  • Revenue
  • LIXT N/A
  • ZAPP $17,440.00
  • Revenue This Year
  • LIXT N/A
  • ZAPP $67,159.17
  • Revenue Next Year
  • LIXT N/A
  • ZAPP $1,149.53
  • P/E Ratio
  • LIXT N/A
  • ZAPP N/A
  • Revenue Growth
  • LIXT N/A
  • ZAPP N/A
  • 52 Week Low
  • LIXT $1.02
  • ZAPP $0.28
  • 52 Week High
  • LIXT $3.50
  • ZAPP $19.10
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 56.57
  • ZAPP 29.22
  • Support Level
  • LIXT $1.26
  • ZAPP $0.26
  • Resistance Level
  • LIXT $1.62
  • ZAPP $0.93
  • Average True Range (ATR)
  • LIXT 0.11
  • ZAPP 0.09
  • MACD
  • LIXT 0.02
  • ZAPP -0.01
  • Stochastic Oscillator
  • LIXT 50.00
  • ZAPP 4.22

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories. Companies founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. The company operates in Cayman Islands, Europe, Thailand. Maximum of revenue is from Thailand.

Share on Social Networks: